Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shunxin Guo

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
IEEE Transactions on Neural Networks and Learning Systems|August 27, 2024
Addressing Skewed Heterogeneity via Federated Prototype Rectification With PersonalizationShunxin Guo, Hongsong Wang, Shuxia Lin, et al.
Chemistry & Biodiversity|April 19, 2008
New stemona alkaloids from the roots of Stemona sessilifoliaAobo Guo, Li Jin, Zhiwei Deng, et al.
Journal of Medicinal Chemistry|March 5, 2026
Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer TherapyLong Zheng, Yiwei Zheng, Sijie Wu, et al.
Journal of Medicinal Chemistry|June 10, 2025
Design and Synthesis of PARP/CDK6 Dual-Target Inhibitors Modulating of Wnt/β-Catenin Signaling Pathway for the Treatment of BRCA Wild-Type TNBCYonglei Zhang, Fucheng Yin, Zhongwen Luo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
IEEE Transactions on Neural Networks and Learning Systems|August 27, 2024
Addressing Skewed Heterogeneity via Federated Prototype Rectification With PersonalizationShunxin Guo, Hongsong Wang, Shuxia Lin, et al.
Chemistry & Biodiversity|April 19, 2008
New stemona alkaloids from the roots of Stemona sessilifoliaAobo Guo, Li Jin, Zhiwei Deng, et al.
Journal of Medicinal Chemistry|March 5, 2026
Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer TherapyLong Zheng, Yiwei Zheng, Sijie Wu, et al.
Journal of Medicinal Chemistry|June 10, 2025
Design and Synthesis of PARP/CDK6 Dual-Target Inhibitors Modulating of Wnt/β-Catenin Signaling Pathway for the Treatment of BRCA Wild-Type TNBCYonglei Zhang, Fucheng Yin, Zhongwen Luo, et al.
Pageof 1